Eight isolates of Desulfovibrio spp. have been obtained over 5 years from abdominal or brain abscesses or blood. In seven patients these strains were part of a mixed flora. One strain was isolated in pure culture from the blood of a patient with peritonitis of appendicular origin. According to the 16S rRNA gene sequences, this strain was close to Desulfovibrio fairfieldensis. The present report describes the fourth isolate of this recently described species to be isolated in pure culture or as a predominant part of the flora and to be associated with infectious processes. Thus, D. fairfieldensis may possess a higher pathogenic potential than other Desulfovibrio species.
A 23-year-old man with gastric ulcer antecedents consulted his practitioner for an epigastric pain, which was suspected of being of gastric origin. On the following day, exacerbation of symptoms necessitated hospitalization at the hospital of SaintAvold (Lorraine region, France). Leukocytosis and abdominal tenderness, which was accentuated in the right iliac fossa, suggested a diagnosis of perforating appendicitis. This was confirmed by surgery, which consisted of appendix removal and peritoneal lavage. Abdominal drainage and empirical intravenous antibiotic therapy with cefamandole (1.5 g per day) and metronidazole (1 g per day) permitted a full recovery. Peritoneal fluid examined by routine bacteriological methods remained sterile. An anaerobic culture of blood obtained at the time of admission was positive and was sent to the Laboratory of Bacteriology of the University Hospital of Nancy for identification of the bacterium.
Bacteriological investigations.
Blood samples were inoculated in anaerobic blood culture vials (Vital; bioMérieux, Marcy l'Etoile, France). Subcultures were performed on Wilkins-Chalgren anaerobic agar at 37°C in an anaerobic chamber. Pinpoint, round, smooth, nonhemolytic, and greyish colonies were observed after 5 days of incubation. Gram staining of the colony showed curved gram-negative rods. The organism was motile and asaccharolytic and tested positive in catalase reactions but negative in oxidase, nitrate reduction, and urease reactions. It produced H 2 S from sulfate. The desulfoviridin test was positive. Growth was detected only under anaerobic conditions at 25, 37, and 42°C. Thus, this bacterium possessed the phenotypic properties of Desulfovibrio spp. (16, 19) .
Antibiotic susceptibility was determined by the agar dilution method with Wilkins-Chalgren medium. Because of the slow growth of this organism, MICs were determined after 96 h of anaerobic incubation at 37°C (13) . MIC results were interpreted with reference to the guidelines of the National Committee for Clinical Laboratory Standards. They indicated that the isolate was resistant to penicillin G (32 g/ml), amoxicillin (32 g/ml), amoxicillin-clavulanate (16 g/ml), ticarcillin (256 g/ml), ticarcillin-clavulanate (256 g/ml), piperacillin (Ͼ256 g/ml), piperacillin-tazobactam (Ͼ256 g/ml), cefoxitin (Ͼ256 g/ml), cefotetan (64 g/ml), and cefotaxime (256 g/ml). It was sensitive to metronidazole (0.25 g/ml), imipenem (0.5 g/ml), and clindamycin (0.5 g/ml).
To obtain a more precise identification of this bacterium, the complete 16S rRNA gene (16S rDNA) sequence of the isolate was determined as described previously (13, 17) . The 16S rDNA sequences of the reference strains Desulfovibrio desulfuricans Essex 6 (type strain, ATCC 29577; isolated from soil), D. desulfuricans MB (ATCC 27774; isolated from sheep rumen), and Desulfomonas pigra (type strain, ATCC 29098; isolated from human feces) were also determined for comparison. Briefly, DNA extracts were obtained from 500 l of bacterial suspension in TE buffer (10 mM Tris-HCl, 1 mM EDTA [pH 8]) by the standard phenol-chloroform-isoamyl alcohol method. The 16S rDNA (about 1,500 nucleotides) was amplified by PCR with the consensus terminal primers 27f and 1525r (17) . PCR products were purified with the Wizard PCR Preps DNA Purification System (Promega Corp., Madison, Wis.) according to the manufacturer's instructions. 16S rDNA sequencing was performed in an automated DNA sequencer (model 373A DNA sequencer; Applied Biosystems Inc., Foster City, Calif.) by the dye-labeled dideoxy chain-termination method (Dye Terminator Cycle Sequencing Ready Reaction Kit; Applied Biosystems Inc.) with terminal and internal primers specific for 16S rDNA (17) . However, the 900r consensus primer was unable to amplify a DNA segment and was then modified according to the D. desulfuricans MB sequence (GenBank accession no. M34113). A total of 1,542 continuous nucleotides of 16S rDNA were determined, and these corresponded to Escherichia coli 16S rDNA sequence positions 8 to 1540 (2) . The complete 16S rDNA sequence of the clinical isolate was compared to all bacterial sequences available from the GenBank database by using the Blast, version 2.0, program (National Center for Biotechnology Institute) and showed 99.9% similarity (corresponding to 2 nucleotide differences) to that of Desulfovibrio fairfieldensis (GenBank accession no. U42221). The sequence of reference strain D. desulfuricans MB had 97.2% similarity (corresponding to 43 nucleotide differences) to the sequence of the same strain deposited in the GenBank database (accession no. M34113). This previously deposited sequence was identical to that determined for D. desulfuricans Essex 6 except for one nucleotide.
Seven other Desulfovibrio clinical strains have been isolated in Nancy, France, over a 5-year period. These seven strains and the strain described above were recovered from seven patients, designated patients 1 to 7 ( Table 1 ). The strains from these patients were labeled D1 to D7, according to patient number, except for those from patient 3, from whom two strains were isolated; the two strains from patient 3 were labeled D31 and D32, respectively (Table 2) . Five strains (strains D1, D2, D31, D5, and D7) were isolated from abscesses, and three strains (strains D32, D4, and D6) were isolated from blood. These eight clinical isolates differed according to their catalase, nitrate reduction, and urease reactions. Only one isolate was in pure culture (strain D4), and this strain could be isolated from the patient described above. The 16S rDNA sequences of these seven clinical isolates were also determined.
Nucleotide sequence accession numbers. The sequences of reference strains Desulfomonas pigra, D. desulfuricans Essex 6, and D. desulfuricans MB and of Desulfovibrio clinical isolate D4 can be recovered from the GenBank database under accession nos. AF192152, AF192153, AF192154, and AF192155, respectively.
The sulfate-reducing eubacteria represent a class of anaerobic microorganisms that conduct dissimilatory sulfate reduction. In this process, sulfate acts as an oxidizing agent for the dissimilation of organic matter, and the reduced sulfur is released into the external environment as sulfide, a toxic and corrosive compound. Thus, these bacteria have detrimental industrial and environmental impacts, such as anaerobic corrosion of steel. They have mostly been isolated from environmental sources (16), but they are also present in the intestinal tracts (6, 16) and mouths (18) of humans and animals. The predominant species in humans belong to the genus Desulfovibrio (5, 20) . Desulfovibrio spp. have been associated with proliferative bowel disease in animals (3, 4, 10, 11), and they have been implicated in ulcerative colitis in humans because of the toxic effects of sulfide, which inhibits butyrate oxidation by colonic epithelial cells (5, 7, 14, 20) . However, their role in (15), and Desulfovibrio vulgaris has been isolated from an intraabdominal abscess (8) . Desulfovibrio spp. have been recovered from appendiceal tissue and peritoneal fluid (1) and from a brain abscess (12) , and three Desulfovibrio strains have recently been isolated from a pyogenic liver abscess (17), blood (13), and a urine specimen (9) . The latter three strains have provisionally been named Desulfovibrio fairfieldensis (17) because of their unique 16S rDNA sequences. According to phenotypic characters and 16S rDNA sequences, the eight Desulfovibrio clinical strains isolated in Nancy can be distributed into three groups: strains D1 and D2 are related to D. desulfuricans Essex 6 (99.4% 16S rDNA similarity), strains D31 and D32 are related to D. desulfuricans MB (99.9% 16S rDNA similarity), and strains D4, D5, D6, and D7 are related to D. fairfieldensis (99.9% 16S rDNA similarity for D4 and D5 and 99.1% 16S rDNA similarity for D6 and D7). The strains in each group show less than 97.3% 16S rDNA similarity with strains of another group (Table 3) . It has been suggested that a 16S rDNA sequence similarity of Ͻ98% is evidence that strains belong to separate species (17) . However, it remains to be determined by more complete phenotypic and genotypic analyses whether these three groups of strains represent different species of Desulfovibrio.
The isolation of Desulfovibrio spp. from human clinical samples might seldom occur because of an absence of systematic searches for the bacteria, the slow and fastidious growth of these bacteria, and the presence of mixed flora. Thus, their prevalence in human diseases may be underestimated. In our series, the outcomes for the seven patients were always favorable once appropriate therapy was undertaken. As is often the case in anaerobic infections, a mixed flora was generally involved. Desulfovibrio spp. may be present in abdominal abscesses as part of the anaerobic intestinal flora. These abscesses are associated with factors that favor infection, such as cirrhosis and previous intestinal surgery, suggesting that Desulfovibrio strains are opportunistic agents with somewhat limited pathogenicities.
Desulfovibrio strains have seldom been isolated in pure culture from clinical samples. D. desulfuricans has been reported in blood (15) . The four additional isolates were from an hepatic abscess, blood, and urine (9, 13, 17) and from blood, as reported above. These four strains have provisionally been labeled D. fairfieldensis and have almost identical 16S rDNA sequences, despite a few phenotypic differences, such as esculin hydrolysis, growth at 25°C, and antibiotic susceptibility profile (differences in resistance or susceptibility to amoxicillinclavulanate, imipenem, ciprofloxacin, and chloramphenicol). They were sensitive to clindamycin and metronidazole, two drugs commonly used for the treatment of anaerobic infections. These four isolates may represent different strains of the same species which remains to be ascertained by further studies. Compared to other Desulfovibrio spp., D. fairfieldensis may have unique properties that confer some invasive power and make this newly described bacterium a potential human pathogen.
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